For decades, scientists have recognized that human immunodeficiency virus (HIV) is a formidable viral pathogen. After years of probing work and extensive experimentation, a Yale research team has unlocked one of the reasons ...
Mar 13, 2026
0
13
People affected by human immunodeficiency virus (HIV), which causes AIDS, did not develop more severe forms of mpox than HIV-negative people during the multiregional outbreak of this disease that occurred in Spain in 2022. ...
Mar 11, 2026
0
4
While the rate of HIV in Kampala, Uganda, is more than double the national average, a recent survey of displaced youths in the city found that only about 20% consistently used condoms and just half of the study participants ...
Mar 9, 2026
0
5
For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune cells from making new copies of the virus, preventing illness and transmission. Historically, these ...
Mar 7, 2026
0
44
How people with compromised immune systems respond to vaccines is an important area of immunological research. A study led by York University has found that not only could machine-learning models accurately pinpoint differences ...
Mar 4, 2026
0
9
Modern HIV treatment is one of medicine's great success stories. With today's therapies, many people living with HIV can expect long, full lives. But as patients age, a new reality has emerged: The biggest threats to their ...
Mar 4, 2026
0
4
A growing number of states are rolling back financial help for HIV medications.
Mar 3, 2026
0
11
Long-acting antiviral medications are transforming HIV prevention and care, requiring only minimalistic dosing. But as the use of lenacapavir expands, scientists are probing a critical question: If the virus evolves resistance, ...
Monthly injections of long-acting cabotegravir-rilpivirine are superior to standard oral antiretroviral therapy (ART) in persons with human immunodeficiency virus (HIV) and medication adherence challenges, according to a ...
Feb 27, 2026
0
17
A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), could effectively replace more complicated HIV treatment regimens used by people living with HIV who are ...
Feb 25, 2026
0
26
